Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
India · Delayed Price · Currency is INR 65.00
-0.95 (-1.44%)
At close: Oct 1, 2026
NSE:AAKAAR Revenue
In the fiscal year ending March 31, 2026, Aakaar Medical Technologies had annual revenue of 669.64M INR with 8.74% growth. Aakaar Medical Technologies had revenue of 416.39M in the half year ending March 31, 2026.
Revenue
669.64M
Revenue Growth
+8.74%
P/S Ratio
1.38
Revenue / Employee
2.50M
Employees
268
Market Cap
921.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 669.64M | 53.81M | 8.74% |
| Mar 31, 2025 | 615.83M | 154.72M | 33.55% |
| Mar 31, 2024 | 461.11M | 133.26M | 40.65% |
| Mar 31, 2023 | 327.85M | 133.19M | 68.43% |
| Mar 31, 2022 | 194.65M | 70.27M | 56.50% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emami | 39.15B |
| Bajaj Consumer Care | 12.33B |
| Anondita Medicare | 1.37B |
| Recode Studios | 799.50M |
| MFL India | 652.28M |
| Ravelcare | 269.54M |
| Paramount Cosmetics (India) | 200.80M |
| Novateor Research Laboratories | 38.27M |